<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE html>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:epub="http://www.idpf.org/2007/ops" xml:lang="EN">
<head>
<meta name="viewport" content="width=840, height=1080"/>
<meta charset="utf-8"/>
<title>The Morphology of Human Blood Cells</title>
<link href="template.css" type="text/css" rel="stylesheet"/>
</head>
<body>
<div>
<img class="stl_03" src="images/043.jpg" alt=""/>
<div class="layer">
<div class="stl_04 stl_05">
<div style="position:absolute; top:3.5724em; left:9.3754em;"><span class="stl_627 stl_31 stl_152" style="word-spacing:0.0053em;">Acute Lymphoblastic Leukemia &#160;</span></div>
<div style="position:absolute; top:2.9841em; left:4.25em;"><span class="stl_628 stl_07 stl_629">15 &#160;</span></div>
<div style="position:absolute; top:12.6667em; left:5.25em;"><span class="stl_630 stl_07 stl_24" style="word-spacing:0.0984em;">Acute lymphoblastic leukemia (ALL) is a malignant disor- &#160;</span></div>
<div style="position:absolute; top:13.6663em; left:5.25em;"><span class="stl_630 stl_07 stl_15" style="word-spacing:-0.0073em;">der that arises from genetic damage that leads to dysregulat- &#160;</span></div>
<div style="position:absolute; top:14.6659em; left:5.25em;"><span class="stl_630 stl_07 stl_61" style="word-spacing:0.0473em;">ed growth of</span><span class="stl_630 stl_07 stl_61" style="word-spacing:0.0763em;"> a</span><span class="stl_630 stl_07 stl_61" style="word-spacing:0.0473em;"> single progenitor cell.</span><span class="stl_630 stl_07 stl_61" style="word-spacing:0.0173em;"> The</span><span class="stl_630 stl_07 stl_61" style="word-spacing:0.0473em;"> incidence of</span><span class="stl_630 stl_07 stl_61" style="word-spacing:0.0563em;"> ALL &#160;</span></div>
<div style="position:absolute; top:15.6655em; left:5.25em;"><span class="stl_630 stl_07 stl_60" style="word-spacing:0.1424em;">reaches a peak between 2 and 7 years of</span><span class="stl_630 stl_07 stl_60" style="word-spacing:0.1724em;"> age</span><span class="stl_630 stl_07 stl_60" style="word-spacing:0.1424em;"> representing &#160;</span></div>
<div style="position:absolute; top:16.6651em; left:5.25em;"><span class="stl_630 stl_07 stl_131" style="word-spacing:0.0745em;">approximately 80% of</span><span class="stl_630 stl_07 stl_131" style="word-spacing:0.1034em;"> acute</span><span class="stl_630 stl_07 stl_131" style="word-spacing:0.0744em;"> leukemia in children less</span><span class="stl_630 stl_07 stl_131" style="word-spacing:0.0744em;"> than &#160;</span></div>
<div style="position:absolute; top:12.6609em; left:26.4998em;"><span class="stl_630 stl_07 stl_24" style="word-spacing:0.2234em;">very poor prognosis and should be considered for bone &#160;</span></div>
<div style="position:absolute; top:13.6605em; left:26.4998em;"><span class="stl_630 stl_07 stl_69" style="word-spacing:0.0153em;">marrow transplantation from a matched sibling if</span><span class="stl_630 stl_07 stl_69" style="word-spacing:0.0453em;"> available. &#160;</span></div>
<div style="position:absolute; top:14.6601em; left:26.4998em;"><span class="stl_630 stl_07 stl_38" style="word-spacing:0.1714em;">Other laboratory findings that should be evaluated in all &#160;</span></div>
<div style="position:absolute; top:15.6597em; left:26.4998em;"><span class="stl_630 stl_07 stl_41" style="word-spacing:0.2059em;">patients with suspicion of</span><span class="stl_630 stl_07 stl_41" style="word-spacing:0.2358em;"> acute</span><span class="stl_630 stl_07 stl_41" style="word-spacing:0.2059em;"> leukemia include</span><span class="stl_630 stl_07 stl_41" style="word-spacing:0.2059em;"> serum &#160;</span></div>
<div style="position:absolute; top:16.6593em; left:26.4998em;"><span class="stl_630 stl_07 stl_55" style="word-spacing:-0.0239em;">uric acid, lactate dehydrogenous (LDH), calcium, APTT, PT, &#160;</span></div>
<div style="position:absolute; top:17.6589em; left:26.4998em;"><span class="stl_630 stl_07 stl_138" style="word-spacing:0.0658em;">and fibrinogen.</span><span class="stl_630 stl_07 stl_138" style="word-spacing:0.0368em;"> Lumbar</span><span class="stl_630 stl_07 stl_138" style="word-spacing:0.0658em;"> puncture should be performed</span><span class="stl_630 stl_07 stl_138" style="word-spacing:0.0658em;"> on &#160;</span></div>
<div style="position:absolute; top:18.6585em; left:26.4998em;"><span class="stl_630 stl_07 stl_41" style="word-spacing:-0.0335em;">all patients newly diagnosed with ALL, to assess involvement &#160;</span></div>
<div style="position:absolute; top:19.6581em; left:26.4998em;"><span class="stl_630 stl_07 stl_36" style="word-spacing:0.052em;">of the</span><span class="stl_630 stl_07 stl_36" style="word-spacing:0.023em;"> CNS. &#160;</span></div>
<div style="position:absolute; top:17.6647em; left:5.25em;"><span class="stl_630 stl_07 stl_61" style="word-spacing:0.0932em;">15 years of</span><span class="stl_630 stl_07 stl_61" style="word-spacing:0.1232em;"> age.</span><span class="stl_630 stl_07 stl_61" style="word-spacing:0.0632em;"> The</span><span class="stl_630 stl_07 stl_61" style="word-spacing:0.0932em;"> current classification of</span><span class="stl_630 stl_07 stl_61" style="word-spacing:0.1032em;"> ALL</span><span class="stl_630 stl_07 stl_61" style="word-spacing:0.0932em;"> relies</span><span class="stl_630 stl_07 stl_61" style="word-spacing:0.0932em;"> on &#160;</span></div>
<div style="position:absolute; top:18.6643em; left:5.25em;"><span class="stl_630 stl_07 stl_69" style="word-spacing:0.0464em;">the immunologic features of</span><span class="stl_630 stl_07 stl_69" style="word-spacing:0.0754em;"> the</span><span class="stl_630 stl_07 stl_69" style="word-spacing:0.0464em;"> leukemic cell and is</span><span class="stl_630 stl_07 stl_69" style="word-spacing:0.0464em;"> deter- &#160;</span></div>
<div style="position:absolute; top:19.6639em; left:5.25em;"><span class="stl_630 stl_07 stl_44" style="word-spacing:0.2771em;">mined by the presence of</span><span class="stl_630 stl_07 stl_44" style="word-spacing:0.2868em;"> surface immunoglobulin</span><span class="stl_630 stl_07 stl_44" style="word-spacing:0.2868em;"> and &#160;</span></div>
<div style="position:absolute; top:20.6635em; left:5.25em;"><span class="stl_630 stl_07 stl_65" style="word-spacing:0.0026em;">T-cell receptor expression. Table 7 depicts current immuno- &#160;</span></div>
<div style="position:absolute; top:21.6631em; left:5.25em;"><span class="stl_630 stl_07 stl_102" style="word-spacing:0.3466em;">logical classifications of ALL and their frequency.</span><span class="stl_630 stl_07 stl_102" style="word-spacing:0.3151em;"> The &#160;</span></div>
<div style="position:absolute; top:22.6627em; left:5.25em;"><span class="stl_630 stl_07 stl_67" style="word-spacing:0.2761em;">immunologic classification has largely replaced the FAB &#160;</span></div>
<div style="position:absolute; top:23.6622em; left:5.25em;"><span class="stl_630 stl_07 stl_122" style="word-spacing:0.0221em;">morphologic classification of</span><span class="stl_630 stl_07 stl_122" style="word-spacing:0.0321em;"> ALL</span><span class="stl_630 stl_07 stl_122" style="word-spacing:0.0321em;"> (</span><span class="stl_631 stl_07 stl_36" style="word-spacing:0.0242em;">TABLE</span><span class="stl_630 stl_07 stl_122" style="word-spacing:0.0807em;"> 8). &#160;</span></div>
<div style="position:absolute; top:21.7271em; left:26.5em;"><span class="stl_632 stl_171 stl_360">Treatment &#160;</span></div>
<div style="position:absolute; top:23.5em; left:26.5em;"><span class="stl_630 stl_07 stl_77" style="word-spacing:0.1448em;">Treatment of ALL includes an induction phase to</span><span class="stl_630 stl_07 stl_77" style="word-spacing:0.1448em;"> achieve &#160;</span></div>
<div style="position:absolute; top:24.4996em; left:26.5em;"><span class="stl_630 stl_07 stl_456" style="word-spacing:0.3367em;">remission and consolidation followed by maintenance &#160;</span></div>
<div style="position:absolute; top:25.4992em; left:26.5em;"><span class="stl_630 stl_07 stl_67" style="word-spacing:0.0254em;">chemotherapy for a total duration of</span><span class="stl_630 stl_07 stl_67" style="word-spacing:0.0562em;"> two</span><span class="stl_630 stl_07 stl_67" style="word-spacing:0.0252em;"> years. &#160;</span></div>
<div style="position:absolute; top:25.7271em; left:5.25em;"><span class="stl_632 stl_171 stl_67" style="word-spacing:0.0221em;">Presentation of</span><span class="stl_632 stl_171 stl_67" style="word-spacing:0.0331em;"> ALL &#160;</span></div>
<div style="position:absolute; top:27.5em; left:5.25em;"><span class="stl_630 stl_07 stl_124" style="word-spacing:-0.0004em;">The onset of</span><span class="stl_630 stl_07 stl_124" style="word-spacing:0.0086em;"> ALL</span><span class="stl_630 stl_07 stl_124" style="word-spacing:-0.0004em;"> is usually acute with symptoms of</span><span class="stl_630 stl_07 stl_124" style="word-spacing:0.0286em;"> fatigue, &#160;</span></div>
<div style="position:absolute; top:28.4996em; left:5.25em;"><span class="stl_630 stl_07 stl_44" style="word-spacing:0.0051em;">malaise, fever, and night sweats. Bone pain, lymphadenopa- &#160;</span></div>
<div style="position:absolute; top:29.4992em; left:5.25em;"><span class="stl_630 stl_07 stl_77" style="word-spacing:0.1236em;">thy, and</span><span class="stl_630 stl_07 stl_77" style="word-spacing:0.1536em;"> hepatosplenomegaly are common and reflect</span><span class="stl_630 stl_07 stl_77" style="word-spacing:0.1536em;"> the &#160;</span></div>
<div style="position:absolute; top:30.4988em; left:5.25em;"><span class="stl_630 stl_07 stl_35" style="word-spacing:0.1477em;">presence of</span><span class="stl_630 stl_07 stl_35" style="word-spacing:0.1767em;"> uncontrolled</span><span class="stl_630 stl_07 stl_35" style="word-spacing:0.1477em;"> growth of</span><span class="stl_630 stl_07 stl_35" style="word-spacing:0.1767em;"> abnormal</span><span class="stl_630 stl_07 stl_35" style="word-spacing:0.1477em;"> cells in</span><span class="stl_630 stl_07 stl_35" style="word-spacing:0.1477em;"> the &#160;</span></div>
<div style="position:absolute; top:31.4984em; left:5.25em;"><span class="stl_630 stl_07 stl_64" style="word-spacing:0.2382em;">bone marrow and lymphoid organs.</span><span class="stl_630 stl_07 stl_64" style="word-spacing:0.2082em;"> Involvement</span><span class="stl_630 stl_07 stl_64" style="word-spacing:0.2382em;"> of</span><span class="stl_630 stl_07 stl_64" style="word-spacing:0.2672em;"> the &#160;</span></div>
<div style="position:absolute; top:32.498em; left:5.25em;"><span class="stl_630 stl_07 stl_41" style="word-spacing:0.0489em;">central nervous system occurs in about 5% of</span><span class="stl_630 stl_07 stl_41" style="word-spacing:0.0779em;"> children</span><span class="stl_630 stl_07 stl_41" style="word-spacing:0.0489em;"> and &#160;</span></div>
<div style="position:absolute; top:28.4009em; left:26.5em;"><span class="stl_633 stl_89 stl_75" style="word-spacing:0.0337em;">Table 7.</span><span class="stl_633 stl_89 stl_75" style="word-spacing:-0.006em;"> Immunologic</span><span class="stl_633 stl_89 stl_75" style="word-spacing:0.0339em;"> Classification of Adult</span><span class="stl_633 stl_89 stl_75" style="word-spacing:0.0339em;"> Acute &#160;</span></div>
<div style="position:absolute; top:29.3173em; left:26.5em;"><span class="stl_633 stl_89 stl_18" style="word-spacing:0.032em;">Lymphoblastic Leukemia &#160;</span></div>
<div style="position:absolute; top:31.0851em; left:26.5em;"><span class="stl_634 stl_166 stl_65">LINEAGE &#160;</span></div>
<div style="position:absolute; top:31.0851em; left:33.059em;"><span class="stl_634 stl_166 stl_635" style="word-spacing:0.0303em;">CELL SURFACE MARKER &#160;</span></div>
<div style="position:absolute; top:31.0851em; left:42.6496em;"><span class="stl_634 stl_166 stl_65">FREQUENCY &#160;</span></div>
<div style="position:absolute; top:32.1278em; left:26.5em;"><span class="stl_636 stl_166 stl_36" style="word-spacing:0.025em;">B cell &#160;</span></div>
<div style="position:absolute; top:33.1287em; left:26.5em;"><span class="stl_637 stl_169 stl_36" style="word-spacing:0.025em;">Early pre-B—ALL &#160;</span></div>
<div style="position:absolute; top:33.1287em; left:33.0599em;"><span class="stl_637 stl_169 stl_36" style="word-spacing:0.0249em;">CD19</span><sup><span class="stl_638a stl_169 stl_67" style="word-spacing:0.0332em;">+</span></sup><span class="stl_637 stl_169 stl_36" style="word-spacing:0.0249em;">, TdT</span><sup><span class="stl_638a stl_169 stl_67" style="word-spacing:0.0332em;">+</span></sup><span class="stl_637 stl_169 stl_36" style="word-spacing:0.0249em;">, HLA-DR &#160;</span></div>
<div style="position:absolute; top:33.1286em; left:43.7484em;"><span class="stl_637 stl_169 stl_36">12 &#160;</span></div>
<div style="position:absolute; top:34.6286em; left:43.7482em;"><span class="stl_637 stl_169 stl_36">50 &#160;</span></div>
<div style="position:absolute; top:36.1286em; left:43.7485em;"><span class="stl_637 stl_169 stl_36">10 &#160;</span></div>
<div style="position:absolute; top:33.4976em; left:5.25em;"><span class="stl_630 stl_07 stl_18" style="word-spacing:0.1549em;">15% of</span><span class="stl_630 stl_07 stl_18" style="word-spacing:0.1839em;"> adults</span><span class="stl_630 stl_07 stl_18" style="word-spacing:0.1549em;"> at the time of</span><span class="stl_630 stl_07 stl_18" style="word-spacing:0.1839em;"> diagnosis</span><span class="stl_630 stl_07 stl_18" style="word-spacing:0.1594em;"> of ALL.</span><span class="stl_630 stl_07 stl_18" style="word-spacing:0.1249em;"> Testicular &#160;</span></div>
<div style="position:absolute; top:34.4972em; left:5.25em;"><span class="stl_630 stl_07 stl_24" style="word-spacing:0.1244em;">leukemia can occur as an isolated relapse in patients with &#160;</span></div>
<div style="position:absolute; top:35.4968em; left:5.25em;"><span class="stl_630 stl_07 stl_80" style="word-spacing:0.027em;">bone marrow remission. &#160;</span></div>
<div style="position:absolute; top:34.6288em; left:33.0589em;"><span class="stl_637 stl_169 stl_81" style="word-spacing:0.0247em;">CD19</span><sup><span class="stl_638a stl_169 stl_87" style="word-spacing:0.0329em;">+</span></sup><span class="stl_637 stl_169 stl_81" style="word-spacing:0.0247em;">, TdT</span><sup><span class="stl_638a stl_169 stl_87" style="word-spacing:0.0329em;">+</span></sup><span class="stl_637 stl_169 stl_81" style="word-spacing:0.0247em;">, CD10</span><sup><span class="stl_638a stl_169 stl_87" style="word-spacing:0.0329em;">+</span></sup><span class="stl_637 stl_169 stl_81" style="word-spacing:0.0247em;">, HLA-DR &#160;</span></div>
<div style="position:absolute; top:34.6288em; left:26.4997em;"><span class="stl_637 stl_169 stl_36">Common—ALL &#160;</span></div>
<div style="position:absolute; top:36.1288em; left:26.5003em;"><span class="stl_637 stl_169 stl_36">Pre-B—ALL &#160;</span></div>
<div style="position:absolute; top:36.1288em; left:33.0594em;"><span class="stl_637 stl_169 stl_36" style="word-spacing:0.025em;">Cytoplasmic Ig</span><sup><span class="stl_638a stl_169 stl_60" style="word-spacing:0.0333em;">+</span></sup><span class="stl_637 stl_169 stl_36" style="word-spacing:0.025em;">, TdT</span><sup><span class="stl_638a stl_169 stl_60" style="word-spacing:0.0333em;">+</span></sup><span class="stl_637 stl_169 stl_36" style="word-spacing:0.025em;">, CD19</span><sup><span class="stl_638a stl_169 stl_60" style="word-spacing:0.0333em;">+ &#160;</span></sup></div>
<div style="position:absolute; top:37.1287em; left:33.0591em;"><span class="stl_637 stl_169 stl_37">CD10</span><sup><span class="stl_638a stl_169 stl_60">+ &#160;</span></sup></div>
<div style="position:absolute; top:37.5605em; left:5.25em;"><span class="stl_632 stl_171 stl_197" style="word-spacing:0.0141em;">Laboratory Studies &#160;</span></div>
<div style="position:absolute; top:38.6286em; left:26.5em;"><span class="stl_637 stl_169 stl_36" style="word-spacing:0.025em;">Mature B cell—ALL &#160;</span></div>
<div style="position:absolute; top:38.6286em; left:33.0592em;"><span class="stl_637 stl_169 stl_132" style="word-spacing:0.0231em;">CD19</span><sup><span class="stl_638a stl_169 stl_138" style="word-spacing:0.0307em;">+</span></sup><span class="stl_637 stl_169 stl_132" style="word-spacing:0.0231em;">, HLA-DR</span><sup><span class="stl_638a stl_169 stl_138" style="word-spacing:0.0307em;">+</span></sup><span class="stl_637 stl_169 stl_132" style="word-spacing:0.0231em;">, surface Ig</span><sup><span class="stl_638a stl_169 stl_138" style="word-spacing:0.0307em;">+ &#160;</span></sup></div>
<div style="position:absolute; top:39.6287em; left:33.0587em;"><span class="stl_637 stl_169 stl_36">CD10 &#160;</span></div>
<div style="position:absolute; top:38.6286em; left:43.9238em;"><span class="stl_637 stl_169 stl_73">4</span></div>
<div style="position:absolute; top:39.3333em; left:5.25em;"><span class="stl_630 stl_07 stl_69" style="word-spacing:0.0744em;">Approximately 50% of</span><span class="stl_630 stl_07 stl_69" style="word-spacing:0.1034em;"> patients</span><span class="stl_630 stl_07 stl_69" style="word-spacing:0.0744em;"> with</span><span class="stl_630 stl_07 stl_69" style="word-spacing:0.0554em;"> ALL</span><span class="stl_630 stl_07 stl_69" style="word-spacing:0.0744em;"> present with</span><span class="stl_630 stl_07 stl_69" style="word-spacing:0.0744em;"> ele- &#160;</span></div>
<div style="position:absolute; top:39.5701em; left:34.5797em;"><span class="stl_638 stl_169 stl_73">±</span></div>
<div style="position:absolute; top:40.3329em; left:5.25em;"><span class="stl_630 stl_07 stl_64" style="word-spacing:0.0075em;">vated white cell counts. Patients with leukocyte count above &#160;</span></div>
<div style="position:absolute; top:41.2296em; left:7.1814em;"><span class="stl_639 stl_07 stl_73">9</span></div>
<div style="position:absolute; top:41.1278em; left:26.5em;"><span class="stl_636 stl_166 stl_36" style="word-spacing:0.025em;">T cell &#160;</span></div>
<div style="position:absolute; top:42.1287em; left:26.5em;"><span class="stl_637 stl_169 stl_36" style="word-spacing:0.025em;">Early T—ALL &#160;</span></div>
<div style="position:absolute; top:41.3325em; left:5.25em;"><span class="stl_630 stl_07 stl_73">5</span></div>
<div style="position:absolute; top:41.3325em; left:5.6379em;"><span class="stl_630 stl_07 stl_44" style="word-spacing:0.1697em;">0x10 /L have a poor prognosis and higher likelihood</span><span class="stl_630 stl_07 stl_44" style="word-spacing:0.1697em;"> of &#160;</span></div>
<div style="position:absolute; top:42.1287em; left:33.0599em;"><span class="stl_637 stl_169 stl_36" style="word-spacing:0.0249em;">TdT</span><sup><span class="stl_638a stl_169 stl_67" style="word-spacing:0.0332em;">+</span></sup><span class="stl_637 stl_169 stl_36" style="word-spacing:0.0249em;">, CD3</span><sup><span class="stl_638a stl_169 stl_67" style="word-spacing:0.0332em;">+</span></sup><span class="stl_637 stl_169 stl_36" style="word-spacing:0.0249em;">, CD7</span><sup><span class="stl_638a stl_169 stl_67" style="word-spacing:0.0332em;">+ &#160;</span></sup></div>
<div style="position:absolute; top:42.1286em; left:43.9238em;"><span class="stl_637 stl_169 stl_73">8</span></div>
<div style="position:absolute; top:42.3329em; left:5.2501em;"><span class="stl_630 stl_07 stl_60" style="word-spacing:0.0504em;">involvement of</span><span class="stl_630 stl_07 stl_60" style="word-spacing:0.0794em;"> the</span><span class="stl_630 stl_07 stl_60" style="word-spacing:0.0504em;"> central nervous system (CNS).</span><span class="stl_630 stl_07 stl_60" style="word-spacing:0.0004em;"> A</span><span class="stl_630 stl_07 stl_60" style="word-spacing:0.0504em;"> subset &#160;</span></div>
<div style="position:absolute; top:43.3325em; left:5.2501em;"><span class="stl_630 stl_07 stl_39" style="word-spacing:0.0735em;">of patients</span><span class="stl_630 stl_07 stl_39" style="word-spacing:0.0445em;"> may present with pancytopenia and no</span><span class="stl_630 stl_07 stl_39" style="word-spacing:0.0445em;"> identifi- &#160;</span></div>
<div style="position:absolute; top:44.3321em; left:5.2501em;"><span class="stl_630 stl_07 stl_20" style="word-spacing:0.0396em;">able blasts in the blood.</span><span class="stl_630 stl_07 stl_20" style="word-spacing:0.0096em;"> Bone</span><span class="stl_630 stl_07 stl_20" style="word-spacing:0.0396em;"> marrow aspiration and</span><span class="stl_630 stl_07 stl_20" style="word-spacing:0.0396em;"> biop- &#160;</span></div>
<div style="position:absolute; top:45.3317em; left:5.2501em;"><span class="stl_630 stl_07 stl_42" style="word-spacing:0.0939em;">sy invariably reveal the presence of</span><span class="stl_630 stl_07 stl_42" style="word-spacing:0.1229em;"> blasts</span><span class="stl_630 stl_07 stl_42" style="word-spacing:0.1229em;"> (</span><span class="stl_631 stl_07 stl_80" style="word-spacing:0.1026em;">PLATES</span><span class="stl_630 stl_07 stl_42" style="word-spacing:0.1304em;"> 58,</span><span class="stl_630 stl_07 stl_42" style="word-spacing:0.0639em;"> 59) &#160;</span></div>
<div style="position:absolute; top:46.3329em; left:5.2502em;"><span class="stl_630 stl_07 stl_111" style="word-spacing:0.1977em;">suggestive of</span><span class="stl_630 stl_07 stl_111" style="word-spacing:0.2277em;"> acute</span><span class="stl_630 stl_07 stl_111" style="word-spacing:0.1977em;"> leukemia.</span><span class="stl_630 stl_07 stl_111" style="word-spacing:0.1677em;"> The</span><span class="stl_630 stl_07 stl_111" style="word-spacing:0.1977em;"> presence of</span><span class="stl_630 stl_07 stl_111" style="word-spacing:0.2277em;"> &gt;5%</span><span class="stl_630 stl_07 stl_111" style="word-spacing:0.1977em;"> blast &#160;</span></div>
<div style="position:absolute; top:47.3325em; left:5.2502em;"><span class="stl_630 stl_07 stl_39" style="word-spacing:0.1154em;">cells is suggestive of</span><span class="stl_630 stl_07 stl_39" style="word-spacing:0.1454em;"> the</span><span class="stl_630 stl_07 stl_39" style="word-spacing:0.1154em;"> diagnosis,</span><span class="stl_630 stl_07 stl_39" style="word-spacing:0.0854em;"> although</span><span class="stl_630 stl_07 stl_39" style="word-spacing:0.1154em;"> in most</span><span class="stl_630 stl_07 stl_39" style="word-spacing:0.1154em;"> cases &#160;</span></div>
<div style="position:absolute; top:43.6288em; left:26.5003em;"><span class="stl_637 stl_169 stl_36" style="word-spacing:0.025em;">Mature T cell—ALL &#160;</span></div>
<div style="position:absolute; top:43.6288em; left:33.0594em;"><span class="stl_637 stl_169 stl_81" style="word-spacing:0.0247em;">TdT</span><sup><span class="stl_638a stl_169 stl_87" style="word-spacing:0.033em;">+</span></sup><span class="stl_637 stl_169 stl_81" style="word-spacing:0.0247em;">, CD3</span><sup><span class="stl_638a stl_169 stl_87" style="word-spacing:0.033em;">+</span></sup><span class="stl_637 stl_169 stl_81" style="word-spacing:0.0247em;">, CD7</span><sup><span class="stl_638a stl_169 stl_87" style="word-spacing:0.033em;">+</span></sup><span class="stl_637 stl_169 stl_81" style="word-spacing:0.0247em;">, CD1</span><sup><span class="stl_638a stl_169 stl_87" style="word-spacing:0.033em;">+</span></sup><span class="stl_637 stl_169 stl_81" style="word-spacing:0.0247em;">, CD2</span><sup><span class="stl_638a stl_169 stl_87" style="word-spacing:0.033em;">+ &#160;</span></sup></div>
<div style="position:absolute; top:43.6286em; left:43.7485em;"><span class="stl_637 stl_169 stl_36">16 &#160;</span></div>
<div style="position:absolute; top:47.0675em; left:26.5em;"><span class="stl_633 stl_89 stl_531" style="word-spacing:0.037em;">Table 8.</span><span class="stl_633 stl_89 stl_531" style="word-spacing:-0.0027em;"> Morphologic</span><span class="stl_633 stl_89 stl_531" style="word-spacing:0.0371em;"> (FAB) Classification of</span><span class="stl_633 stl_89 stl_531" style="word-spacing:0.0371em;"> Acute &#160;</span></div>
<div style="position:absolute; top:47.984em; left:26.5em;"><span class="stl_633 stl_89 stl_133" style="word-spacing:0.0309em;">Lymphoblastic Leukemia (Plate 59) &#160;</span></div>
<div style="position:absolute; top:48.3321em; left:5.2502em;"><span class="stl_630 stl_07 stl_16" style="word-spacing:0.0756em;">&gt;50% lymphoblasts are present in the bone marrow.</span><span class="stl_630 stl_07 stl_16" style="word-spacing:0.0456em;"> Lym- &#160;</span></div>
<div style="position:absolute; top:49.3317em; left:5.2502em;"><span class="stl_630 stl_07 stl_99" style="word-spacing:0.0572em;">phoblasts usually stain positively for TdT,</span><span class="stl_630 stl_07 stl_99" style="word-spacing:0.0272em;"> but</span><span class="stl_630 stl_07 stl_99" style="word-spacing:0.0572em;"> a</span><span class="stl_630 stl_07 stl_99" style="word-spacing:0.0572em;"> proportion &#160;</span></div>
<div style="position:absolute; top:50.3313em; left:5.2502em;"><span class="stl_630 stl_07 stl_20" style="word-spacing:0.0826em;">of ALL</span><span class="stl_630 stl_07 stl_20" style="word-spacing:0.0726em;"> may be TdT negative.</span><span class="stl_630 stl_07 stl_20" style="word-spacing:0.0426em;"> Immunophenotyping</span><span class="stl_630 stl_07 stl_20" style="word-spacing:0.0726em;"> is</span><span class="stl_630 stl_07 stl_20" style="word-spacing:0.0726em;"> very &#160;</span></div>
<div style="position:absolute; top:51.3309em; left:5.2502em;"><span class="stl_630 stl_07 stl_81" style="word-spacing:0.0927em;">important in</span><span class="stl_630 stl_07 stl_81" style="word-spacing:0.0727em;"> ALL</span><span class="stl_630 stl_07 stl_81" style="word-spacing:0.0927em;"> since it is used for classification and</span><span class="stl_630 stl_07 stl_81" style="word-spacing:0.0927em;"> for &#160;</span></div>
<div style="position:absolute; top:52.3305em; left:5.2502em;"><span class="stl_630 stl_07 stl_122" style="word-spacing:-0.0299em;">prognostic indications and sometimes to determine the type &#160;</span></div>
<div style="position:absolute; top:53.3301em; left:5.2502em;"><span class="stl_630 stl_07 stl_187" style="word-spacing:0.0657em;">of treatment</span><span class="stl_630 stl_07 stl_187" style="word-spacing:0.0367em;"> to be administered.</span><span class="stl_630 stl_07 stl_187" style="word-spacing:0.0057em;"> Differentiating</span><span class="stl_630 stl_07 stl_187" style="word-spacing:0.0367em;"> B- from</span><span class="stl_630 stl_07 stl_187" style="word-spacing:0.0367em;"> T- &#160;</span></div>
<div style="position:absolute; top:54.3297em; left:5.2502em;"><span class="stl_630 stl_07 stl_45" style="word-spacing:0.025em;">cell ALL</span><span class="stl_630 stl_07 stl_45" style="word-spacing:0.045em;"> is very important at initial evaluation and prior</span><span class="stl_630 stl_07 stl_45" style="word-spacing:0.045em;"> to &#160;</span></div>
<div style="position:absolute; top:55.3293em; left:5.2502em;"><span class="stl_630 stl_07 stl_24" style="word-spacing:-0.0037em;">treatment. Cytogenetic</span><span class="stl_630 stl_07 stl_24" style="word-spacing:0.0263em;"> and molecular studies provide</span><span class="stl_630 stl_07 stl_24" style="word-spacing:0.0263em;"> valu- &#160;</span></div>
<div style="position:absolute; top:56.3289em; left:5.2502em;"><span class="stl_630 stl_07 stl_39" style="word-spacing:0.0464em;">able information to determine the therapeutic intervention &#160;</span></div>
<div style="position:absolute; top:57.3285em; left:5.2502em;"><span class="stl_630 stl_07 stl_36" style="word-spacing:0.3041em;">and the prognostic features of</span><span class="stl_630 stl_07 stl_36" style="word-spacing:0.3137em;"> new patients with</span><span class="stl_630 stl_07 stl_36" style="word-spacing:0.2841em;"> ALL. &#160;</span></div>
<div style="position:absolute; top:58.3281em; left:5.2502em;"><span class="stl_630 stl_07 stl_64" style="word-spacing:0.0383em;">Approximately 20% of</span><span class="stl_630 stl_07 stl_64" style="word-spacing:0.0672em;"> adult</span><span class="stl_630 stl_07 stl_64" style="word-spacing:0.0192em;"> ALL</span><span class="stl_630 stl_07 stl_64" style="word-spacing:0.0382em;"> patients have the</span><span class="stl_630 stl_07 stl_64" style="word-spacing:0.0382em;"> translo- &#160;</span></div>
<div style="position:absolute; top:59.3277em; left:5.2502em;"><span class="stl_630 stl_07 stl_15" style="word-spacing:0.1765em;">cation (9,22) by cytogenetic analysis.</span><span class="stl_630 stl_07 stl_15" style="word-spacing:0.1475em;"> These</span><span class="stl_630 stl_07 stl_15" style="word-spacing:0.1765em;"> patients</span><span class="stl_630 stl_07 stl_15" style="word-spacing:0.1765em;"> have &#160;</span></div>
<div style="position:absolute; top:49.7517em; left:30.9601em;"><span class="stl_634 stl_166 stl_65">DESCRIPTION &#160;</span></div>
<div style="position:absolute; top:51.0452em; left:26.5em;"><span class="stl_637 stl_169 stl_36" style="word-spacing:0.025em;">Small blasts:</span><span class="stl_637 stl_169 stl_36" style="word-spacing:1.038em;"> High</span><span class="stl_637 stl_169 stl_36" style="word-spacing:0.025em;"> nuclear to cytoplasmic ratio,</span><span class="stl_637 stl_169 stl_36" style="word-spacing:0.025em;"> homogeneous &#160;</span></div>
<div style="position:absolute; top:52.1283em; left:30.9604em;"><span class="stl_637 stl_169 stl_36" style="word-spacing:0.025em;">but condensed nuclear chromatin, no</span><span class="stl_637 stl_169 stl_36" style="word-spacing:-0.001em;"> or</span><span class="stl_637 stl_169 stl_36" style="word-spacing:0.025em;"> indistinct &#160;</span></div>
<div style="position:absolute; top:53.2119em; left:30.9601em;"><span class="stl_637 stl_169 stl_36" style="word-spacing:0.025em;">nucleoli, scanty cytoplasm (L1) &#160;</span></div>
<div style="position:absolute; top:54.545em; left:26.4997em;"><span class="stl_637 stl_169 stl_36" style="word-spacing:0.025em;">Larger blasts:</span><span class="stl_637 stl_169 stl_36" style="word-spacing:0.711em;"> Irregular</span><span class="stl_637 stl_169 stl_36" style="word-spacing:0.025em;"> membrane, homogeneous with</span><span class="stl_637 stl_169 stl_36" style="word-spacing:-0.001em;"> fine</span><span class="stl_637 stl_169 stl_36" style="word-spacing:0.025em;"> nuclear &#160;</span></div>
<div style="position:absolute; top:55.5451em; left:30.9601em;"><span class="stl_637 stl_169 stl_36" style="word-spacing:0.025em;">chromatin, one or more nucleoli, moderately abun- &#160;</span></div>
<div style="position:absolute; top:56.5453em; left:30.9601em;"><span class="stl_637 stl_169 stl_36" style="word-spacing:0.025em;">dant blue cytoplasm (L2) &#160;</span></div>
<div style="position:absolute; top:57.962em; left:26.4997em;"><span class="stl_637 stl_169 stl_36" style="word-spacing:0.025em;">Large blasts:</span><span class="stl_637 stl_169 stl_36" style="word-spacing:1.039em;"> Round</span><span class="stl_637 stl_169 stl_36" style="word-spacing:0.025em;"> to oval nucleus, fine nuclear</span><span class="stl_637 stl_169 stl_36" style="word-spacing:0.025em;"> chromatin, &#160;</span></div>
<div style="position:absolute; top:59.045em; left:30.9601em;"><span class="stl_637 stl_169 stl_36" style="word-spacing:0.025em;">prominent nucleoli, intense blue cytoplasm, often &#160;</span></div>
<div style="position:absolute; top:60.1286em; left:30.9601em;"><span class="stl_637 stl_169 stl_36" style="word-spacing:0.025em;">vacuolated (L3) &#160;</span></div>
<div style="position:absolute; top:64.0452em; left:47.9161em;"><span class="stl_640 stl_89 stl_210">35 &#160;</span></div>
</div>
</div>
</div>
</body>
</html>
